CliffBio
small molecule

GLUCAGON

GLUCAGON HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameGLUCAGON
Active ingredientGLUCAGON HYDROCHLORIDE
StrengthEQ 1MG BASE/VIAL
Dosage formPOWDER
RouteINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
ModalitySmall molecule
FDA approvalSeptember 2019
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.